Type2 Diabetes Mellitus Remission After Sleeve Gastrectomy in Patients 60 Years and Older-A Multicenter Study
In brief
Sleeve gastrectomy brought diabetes remission to 62% of patients aged 60 and older
In a multicenter retrospective study of 129 patients aged 60 and older, 80 achieved type 2 diabetes remission at final follow-up, after a median of 6 years. Remission was less likely when diabetes had lasted more than 10 years before surgery, but the study cannot show that earlier surgery itself improves outcomes; remission durability also remains uncertain.
- Journal
- Journal of clinical medicine (Q1)
- Published
- 5 November 2026
- Study design
- Retrospective cohort
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Pawel Jaworski, Mateusz Wityk, Piotr Major, Wiesław Tarnowski, Natalia Dowgiałło-Gornowicz
- PMID
- 43030754
- DOI
- 10.3390/jcm15218613
Why clinicians should know about it
- Picked for Bariatric and Metabolic Surgery (paper of the day, 16 November 2026): Long-term diabetes remission after sleeve in older adults
Abstract
Introduction: Driven by impaired insulin secretion and insulin resistance, type 2 diabetes mellitus (T2DM) stands as a chronic metabolic disorder. While metabolic bariatric surgery (MBS) is highly effective, data on older populations remain limited. The objective of this study is to assess the long-term outcomes and clinical predictors of T2DM remission in patients aged 60 and older following sleeve gastrectomy. Materials and Methods: This retrospective cohort study evaluates data retrieved from the medical records of 129 patients aged ≥60 years with T2DM who underwent primary laparoscopic sleeve gastrectomy between 2008 and 2022. Baseline demographic characteristics, body mass index (BMI), T2DM duration, and treatment modalities were extracted. Metabolic outcomes, including total weight loss (%TWL) and excess weight loss (%EWL), were evaluated over a median follow-up of 6.0 years. Results: The cohort had a median age of 66 years, with females accounting for 62% of the population. At the final follow-up, the median %TWL was 19.4%, and the median %EWL was 47.8%. Overall, T2DM remission was achieved in 80 (62.0%) patients, whereas 16 (12.4%) patients experienced no clinical changes. Duration of T2DM of more than 10 years was associated with a lower likelihood of remission of T2DM (p = 0.007). Conclusions: Our findings demonstrate that a substantial proportion of patients aged 60 years and older achieved T2DM remission at the last available follow-up following sleeve gastrectomy. A decreased likelihood of remission correlated with longer preoperative T2DM duration, which highlights the clinical value of offering metabolic surgery early to eligible older patients.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.